North America Point Of Care Diagnostics Market Is Increasing Due To Increased Incidence Rate Of Chronic & Infectious Diseases Till 2024: Grand View Research, Inc.
The North America point of care diagnostics market is
anticipated to reach USD 8.95 billion by 2024, according to a new report by
Grand View Research, Inc. Incorporation of advanced information technology
solutions coupled with the launch of innovative POC products with automation
and ease of use is projected to influence market progression during the
forecast period.
Moreover,
the rising adoption rate of the POC devices in order to obtain quick results
for immediate decision making for patient management is expected to provide the
market with lucrative growth avenues. Additionally, the regulatory initiatives
introduced for patient care management and rising prevalence of various
diseases is attributive to boost demand for these products in the coming years.
The
presence of a favorable funding environment in the region is attributive to
drive R&D in academic organizations and universities thereby resulting to
industrial progress through to 2024.
North
America Point of Care Diagnostics Market, By Product, 2013 - 2024 (USD Million)
Browse full
research report on North America Point Of Care Diagnostics Market: http://www.grandviewresearch.com/industry-analysis/north-america-point-of-care-poc-diagnostics-market
Further key
findings from the report suggest:
- Glucose testing accounted for the largest share
of over 41% of the market in 2015 with respect to revenue generation.
Factors attributive for the estimated large share includes presence of
comprehensive product portfolio provided by the local as well as
international market participants. Moreover, rise in the prevalence of
diabetes in chronic patients and need for monitoring glucose levels is
also supportive for revenue generation of this segment.
- Infectious diseases point-of-care tests are
expected to witness the fastest growth in the coming years owing to the
R&D carried out in this segment for an introduction of novel tests.
Infectious disease testing segments include kits for various diseases such
as HIV, HBV, respiratory syncytial virus (RSV), pneumonia or streptococcus
associated infections, HPV, influenza/flu, HCV, MRSA, Clostridium
difficile, TB &drug-resistant TB, and HSV.
- Cardiac markers are also anticipated to
register substantial growth as a result of an increase in incidence rate
of cholesterol associated disorders and rise in the number of cases of
congestive heart failure.
- Clinics dominated the POC diagnostic market in
2015 due to higher usage of these tests in clinics. However, home settings
for POC diagnostics are anticipated to witness the fastest growth owing to
rising usage of home health care settings for disease monitoring in the
geriatric population.
- Assisted living healthcare facilities are also
anticipated to witness considerable growth during the forecast period due
to the property of rapid diagnostic products to enable simple usage at
primary care level and in remote settings even with no laboratory
infrastructure
- Prominent players of this industry include
Qiagen N.V., Spectral Diagnostics, Abbott Laboratories, Siemens
Healthcare, Instrumentation Laboratory, Danaher Corporation, BioMerieux,
Johnson & Johnson, Abaxis Inc., Roche Diagnostics, Alere Inc., Nova
Biomedical, Nipro Diagnostics, and Trinity Biotech.
- Strategies adopted by the market players
include mergers and acquisitions with the smaller entities operating in
market for enhancement of the product portfolio. The participants are
involved introduction of new solutions, and collaborations with heath care
institutions in order to maintain their global presence.
Browse more
reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented North America point of care
diagnostics market on the basis of product, end-use, and region:
North
America Point of Care Diagnostics Outlook, by Product (Revenue, USD Million,
2013 - 2024)
- Glucose
Testing
- Hb1Ac
Testing
- Coagulation
- Fertility
- Cardiac
markers
- Infectious
diseases
- HIV POC
- Clostridium
difficile POC
- HBV POC
- Pneumonia
or Streptococcus associated infections
- Respiratory
syncytial virus (RSV) POC
- HPV POC
- Influenza/Flu
POC
- HCV POC
- MRSA
POC
- TB and
drug-resistant TB POC
- HSV POC
- Other
Infectious Diseases
- Primary
care systems
- Hematology
- Decentralized
Clinical Chemistry
- Feces
- Blood
Gas/Electrolytes
- Ambulatory
Chemistry
- Urinalysis
- Drug
Abuse Testing
North
America Point of Care Diagnostics Outlook, by End-use (Revenue, USD Million,
2013 - 2024)
- Clinics
- Hospitals
- Assisted
Living Healthcare Facilities
- Laboratory
- Others
North
America Point of Care Diagnostics Regional Outlook (Revenue, USD Million,
2013 - 2024)
- North
America
- U.S.
- Canada
Access
Press Release By Grand View Research: http://www.grandviewresearch.com/press
release/north-america-point-of-care-poc-diagnostics-market-analysis
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
Comments
Post a Comment